Previous
Previous
January 17

Advances in motion highlights our identification of stathmin-2 as a novel therapeutic target in TDP43-mediated ALS/FTD

Next
Next
February 14

Clotilde gives the 2019 Lisa S. Krivickas Lecture at the Massachusetts General Hospital Neurology Grand Rounds